| Trial | Treatments | Patients | Method |
|---|
| Beelen, 2014 | (n=-9) vs. (n=-9) | | Sample size: -9/-9 Primary endpoint: FU duration: |
| Beex, 2006 | (n=-9) vs. (n=-9) | first line endocrine treatment in advanced breast | Sample size: -9/-9 Primary endpoint: FU duration: |
| Sawka, 1997 | (n=-9) vs. (n=-9) | metastatic breast cancer in premenopausal women | Sample size: -9/-9 Primary endpoint: FU duration: |
| Kuss, 1997 | (n=-9) vs. (n=-9) | | Sample size: -9/-9 Primary endpoint: FU duration: |
| Stuart, 1996 | (n=-9) vs. (n=-9) | advanced and recurrent breast cancer | Sample size: -9/-9 Primary endpoint: FU duration: |
| Willsher, 1996 | (n=-9) vs. (n=-9) | Locally advanced breast cancer | Sample size: -9/-9 Primary endpoint: FU duration: |
| Muss, 1994 | (n=-9) vs. (n=-9) | patients with metastatic breast cancer | Sample size: -9/-9 Primary endpoint: FU duration: |
| Gill, 1993 | (n=-9) vs. (n=-9) | patients with metastatic breast cancer | Sample size: -9/-9 Primary endpoint: FU duration: |
| Castiglione-Gertsch, 1993 | (n=-9) vs. (n=-9) | | Sample size: -9/-9 Primary endpoint: FU duration: |
| Spooner, 1991 | (n=-9) vs. (n=-9) | advanced breast cancer | Sample size: -9/-9 Primary endpoint: FU duration: |
| De Lena, 1990 | (n=-9) vs. (n=-9) | advanced breast cancer | Sample size: -9/-9 Primary endpoint: FU duration: |
| Takatsuka, 1989 | (n=-9) vs. (n=-9) | advanced breast cancer | Sample size: -9/-9 Primary endpoint: FU duration: |
| Kellokumpu-Lehtinen, 1987 | (n=-9) vs. (n=-9) | advanced breast cancer | Sample size: -9/-9 Primary endpoint: FU duration: |
| Ettinger, 1986 | (n=-9) vs. (n=-9) | advanced breast cancer | Sample size: -9/-9 Primary endpoint: FU duration: |
| Gockerman, 1986 | (n=-9) vs. (n=-9) | | Sample size: -9/-9 Primary endpoint: FU duration: |
| Buchanan, 1986 | (n=-9) vs. (n=-9) | premenopausal patients with advanced breast cancer | Sample size: -9/-9 Primary endpoint: FU duration: |
| van, 1986 | (n=-9) vs. (n=-9) | | Sample size: -9/-9 Primary endpoint: FU duration: |
| Ingle, 1986 | (n=-9) vs. (n=-9) | | Sample size: -9/-9 Primary endpoint: FU duration: |
| Mauriac, 1986 | (n=-9) vs. (n=-9) | | Sample size: -9/-9 Primary endpoint: FU duration: |
| Viladiu, 1985 | (n=-9) vs. (n=-9) | | Sample size: -9/-9 Primary endpoint: FU duration: |
| Mouridsen, 1985 | (n=-9) vs. (n=-9) | | Sample size: -9/-9 Primary endpoint: FU duration: |
| Perry, 1985 | (n=-9) vs. (n=-9) | | Sample size: -9/-9 Primary endpoint: FU duration: |
